Church & Dwight (NYSE:CHD) Price Target Raised to $90.00

Church & Dwight (NYSE:CHD) had its price objective lifted by Barclays from $85.00 to $90.00 in a research note released on Friday,Benzinga reports. The firm currently has an underweight rating on the stock.

Several other research firms have also weighed in on CHD. Piper Sandler increased their target price on Church & Dwight from $124.00 to $128.00 and gave the company an “overweight” rating in a research note on Monday, January 6th. Wells Fargo & Company upped their target price on shares of Church & Dwight from $113.00 to $115.00 and gave the stock an “overweight” rating in a research note on Monday, November 4th. JPMorgan Chase & Co. upped their price objective on Church & Dwight from $99.00 to $107.00 and gave the stock an “underweight” rating in a research report on Thursday. TD Cowen lifted their target price on Church & Dwight from $114.00 to $117.00 and gave the company a “buy” rating in a research report on Monday, November 4th. Finally, Deutsche Bank Aktiengesellschaft upped their price target on Church & Dwight from $114.00 to $115.00 and gave the stock a “buy” rating in a research report on Monday, November 4th. Two analysts have rated the stock with a sell rating, eight have assigned a hold rating and eight have given a buy rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Hold” and a consensus target price of $110.61.

Church & Dwight Trading Up 0.1 %

Shares of NYSE CHD opened at $106.42 on Friday. Church & Dwight has a 1-year low of $96.09 and a 1-year high of $113.50. The company has a 50-day moving average of $106.86 and a two-hundred day moving average of $104.05. The company has a market cap of $26.07 billion, a PE ratio of 47.72, a P/E/G ratio of 3.12 and a beta of 0.58. The company has a current ratio of 1.62, a quick ratio of 1.09 and a debt-to-equity ratio of 0.53.

Church & Dwight (NYSE:CHD) last posted its quarterly earnings data on Friday, November 1st. The company reported $0.79 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.68 by $0.11. The firm had revenue of $1.51 billion for the quarter, compared to the consensus estimate of $1.50 billion. Church & Dwight had a return on equity of 19.90% and a net margin of 9.08%. The business’s revenue for the quarter was up 3.8% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.74 EPS. As a group, equities analysts expect that Church & Dwight will post 3.44 earnings per share for the current fiscal year.

Church & Dwight Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Monday, December 2nd. Stockholders of record on Friday, November 15th were given a $0.2838 dividend. The ex-dividend date was Friday, November 15th. This represents a $1.14 dividend on an annualized basis and a dividend yield of 1.07%. Church & Dwight’s payout ratio is 50.67%.

Insider Buying and Selling

In related news, CAO Joseph James Longo sold 7,780 shares of the business’s stock in a transaction on Friday, November 22nd. The stock was sold at an average price of $112.44, for a total value of $874,783.20. Following the completion of the sale, the chief accounting officer now directly owns 400 shares in the company, valued at $44,976. The trade was a 95.11 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CEO Matthew Farrell sold 300,000 shares of the stock in a transaction on Wednesday, November 6th. The stock was sold at an average price of $103.84, for a total value of $31,152,000.00. Following the transaction, the chief executive officer now owns 112,719 shares in the company, valued at $11,704,740.96. The trade was a 72.69 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 593,035 shares of company stock valued at $62,282,808. 2.00% of the stock is owned by insiders.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the business. State Street Corp grew its position in Church & Dwight by 8.0% during the third quarter. State Street Corp now owns 13,116,334 shares of the company’s stock worth $1,373,542,000 after buying an additional 969,006 shares in the last quarter. Massachusetts Financial Services Co. MA grew its holdings in shares of Church & Dwight by 5.7% during the 3rd quarter. Massachusetts Financial Services Co. MA now owns 8,016,345 shares of the company’s stock worth $839,472,000 after purchasing an additional 429,863 shares in the last quarter. Stifel Financial Corp increased its position in shares of Church & Dwight by 0.5% in the third quarter. Stifel Financial Corp now owns 4,295,527 shares of the company’s stock worth $449,830,000 after purchasing an additional 21,607 shares during the period. Allspring Global Investments Holdings LLC increased its position in shares of Church & Dwight by 5.5% in the third quarter. Allspring Global Investments Holdings LLC now owns 3,358,179 shares of the company’s stock worth $351,668,000 after purchasing an additional 175,221 shares during the period. Finally, Charles Schwab Investment Management Inc. raised its stake in Church & Dwight by 1.2% in the third quarter. Charles Schwab Investment Management Inc. now owns 1,399,502 shares of the company’s stock valued at $146,556,000 after purchasing an additional 16,257 shares in the last quarter. 86.60% of the stock is owned by institutional investors.

About Church & Dwight

Church & Dwight Co, Inc engages in the development, manufacture, and marketing of household, personal care, and specialty products. It operates through the following segments: Consumer Domestic, Consumer International, Specialty Products, and Corporate. The Consumer Domestic segment offers household products, such as laundry detergents, fabric softener sheets, cat litter, and household cleaning products, and personal care products including antiperspirants, oral care products, depilatories, reproductive health products, oral analgesics, nasal saline moisturizers, and dietary supplements.